Autologous CD4+ T-cell infusion induces regression of tumour

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1644, 2008-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-CD4 monoclonal antibody/tumour necrosis factor α inhibitors: Cytokine release syndromes, allergy, CD4+ T-cell lymphopenia and maculopapular rash: 8 case reports

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Race and CD4⁺ T-cell count in HIV prognosis and treatment

By Achhra Amit C Amin Janaki

Future Virology, Vol. 7, Iss. 2, 2012-02 ,pp. : 193-203

Future Medicine

Access to resources Recommend Favorite

CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 4, 2006-12 ,pp. : 239-242

Bentham Science Publishers

Access to resources Recommend Favorite

XII. Therapeutic exploitation of autologous T‐cell activation in B‐cell lymphoma

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 67-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alefacept/methotrexate: Persistent CD4+ T-cell depression: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite